• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IRF8的缺失会抑制急性髓系白血病细胞的生长。

Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.

作者信息

Zhuang Haihui, Li Fenglin, Xu Yulian, Pei Renzhi, Chen Dong, Liu Xuhui, Li Shuangyue, Ye Peipei, Yuan Jiaojiao, Lian Jiaying, Lu Ying

机构信息

Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.

Institute of Hematology, Ningbo University, Baizhang Road 251#, Ningbo, China.

出版信息

Ann Hematol. 2023 May;102(5):1063-1072. doi: 10.1007/s00277-023-05156-y. Epub 2023 Mar 23.

DOI:10.1007/s00277-023-05156-y
PMID:36959484
Abstract

The transcription factor interferon regulatory factor 8 (IRF8), as a member of the IRF family, is essential for myeloid cell differentiation. However, the precise role of IRF8 in the pathogenesis of acute myeloid leukemia (AML) remains unknown. By using multivariate analysis, we discovered that high IRF8 expression was an independent poor predictor of overall survival (OS) in AML patients from our clinical follow-up study. The proliferation of three AML cell lines was significantly inhibited by shRNA-mediated knockdown of IRF8, owing to cell cycle S-phase arrest. Furthermore, we demonstrated that knocking down IRF8 could suppress the expression of CyclinA and CyclinB1, resulting in a shift in cell cycle distribution. Loss of IRF8 in AML cells decreased the expression of STAT3 and phosphor-STAT3 (pSTAT3), which are key factors in JAK/STAT signal pathway and are important for AML progression. Using a xenograft mouse model, we discovered the antiproliferative effect of losing IRF8 in vivo. In conclusion, this study found that IRF8 may play a prognostic factor and therapeutic target in AML.

摘要

转录因子干扰素调节因子8(IRF8)作为IRF家族的一员,对髓系细胞分化至关重要。然而,IRF8在急性髓系白血病(AML)发病机制中的具体作用仍不清楚。通过多变量分析,我们从临床随访研究中发现,高IRF8表达是AML患者总生存期(OS)的一个独立不良预测指标。由于细胞周期S期阻滞,shRNA介导的IRF8敲低显著抑制了三种AML细胞系的增殖。此外,我们证明敲低IRF8可抑制细胞周期蛋白A(CyclinA)和细胞周期蛋白B1(CyclinB1)的表达,导致细胞周期分布发生改变。AML细胞中IRF8的缺失降低了信号转导和转录激活因子3(STAT3)及磷酸化STAT3(pSTAT3)的表达,它们是JAK/STAT信号通路中的关键因子,对AML进展很重要。利用异种移植小鼠模型,我们发现体内缺失IRF8具有抗增殖作用。总之,本研究发现IRF8可能是AML的一个预后因素和治疗靶点。

相似文献

1
Loss of IRF8 inhibits the growth of acute myeloid leukemia cells.IRF8的缺失会抑制急性髓系白血病细胞的生长。
Ann Hematol. 2023 May;102(5):1063-1072. doi: 10.1007/s00277-023-05156-y. Epub 2023 Mar 23.
2
ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.ZMYND8 调控的 IRF8 转录轴是急性髓系白血病的一个依赖性。
Mol Cell. 2021 Sep 2;81(17):3604-3622.e10. doi: 10.1016/j.molcel.2021.07.018. Epub 2021 Aug 5.
3
Nore1 inhibits age-associated myeloid lineage skewing and clonal hematopoiesis but facilitates termination of emergency (stress) granulopoiesis.Nore1 抑制与年龄相关的髓系谱系偏倚和克隆性造血,但促进应急(应激)粒细胞生成的终止。
J Biol Chem. 2023 Jul;299(7):104867. doi: 10.1016/j.jbc.2023.104867. Epub 2023 May 27.
4
Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.转录因子 IRF4 和 IRF8 在髓系细胞发育中的共享和独特功能。
PLoS One. 2011;6(10):e25812. doi: 10.1371/journal.pone.0025812. Epub 2011 Oct 7.
5
IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.IRF8 通过调节酸性鞘磷脂酶的表达来介导细胞凋亡,从而抑制髓性白血病。
Cancer Res. 2011 Apr 15;71(8):2882-91. doi: 10.1158/0008-5472.CAN-10-2493. Epub 2011 Apr 12.
6
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia.IRF8 转录本在成人急性髓系白血病患者中的预后意义。
PLoS One. 2013 Aug 14;8(8):e70812. doi: 10.1371/journal.pone.0070812. eCollection 2013.
7
Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis.丝氨酸丰富的精原细胞瘤相关蛋白 2 样通过调控 JAK2/STAT3/STAT5 轴在急性髓系白血病中发挥预后因子和治疗靶点的作用。
J Transl Med. 2023 Feb 11;21(1):115. doi: 10.1186/s12967-023-03968-0.
8
The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.粒细胞祖细胞阶段是IRF8介导的髓源性抑制细胞产生调控的关键靶点。
J Immunol. 2017 May 15;198(10):4129-4139. doi: 10.4049/jimmunol.1601722. Epub 2017 Mar 29.
9
Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling.IRF8 的组成型表达通过激活受抑制的免疫反应信号来抑制 AML。
Leukemia. 2015 Jan;29(1):157-68. doi: 10.1038/leu.2014.162. Epub 2014 May 20.
10
Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.SMIM3 的下调通过 PI3K-AKT 信号通路抑制白血病的生长,与正常核型成人急性髓细胞白血病的预后相关。
J Transl Med. 2022 Dec 22;20(1):612. doi: 10.1186/s12967-022-03831-8.

引用本文的文献

1
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.双氢青蒿素与维奈托克联合使用通过C-MYC/BCL-XL/MCL-1三联靶向增强急性髓系白血病的抗肿瘤作用。
Discov Oncol. 2025 Apr 9;16(1):496. doi: 10.1007/s12672-025-02242-7.
2
Alternative Splicing as a Modulator of the Interferon-Gamma Pathway.可变剪接作为干扰素-γ 通路的调节因子
Cancers (Basel). 2025 Feb 10;17(4):594. doi: 10.3390/cancers17040594.
3
High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.

本文引用的文献

1
A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia.一个独特的核心调控模块可在 KMT2A 重排白血病中强制表达癌基因。
Genes Dev. 2022 Mar 1;36(5-6):368-389. doi: 10.1101/gad.349284.121. Epub 2022 Mar 17.
2
Targeting Chemotherapy to Decondensed H3K27me3-Marked Chromatin of AML Cells Enhances Leukemia Suppression.针对 AML 细胞中去凝聚的 H3K27me3 标记染色质的化疗增强白血病抑制。
Cancer Res. 2022 Feb 1;82(3):458-471. doi: 10.1158/0008-5472.CAN-21-1297. Epub 2021 Dec 13.
3
Advances in acute myeloid leukemia.
GPR183高表达预示细胞遗传学正常的急性髓系白血病患者预后不良。
Biochem Genet. 2025 Jan 16. doi: 10.1007/s10528-025-11026-1.
4
The multiple roles of interferon regulatory factor family in health and disease.干扰素调节因子家族在健康和疾病中的多重作用。
Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4.
急性髓细胞白血病的研究进展。
BMJ. 2021 Oct 6;375:n2026. doi: 10.1136/bmj.n2026.
4
International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts.国际人类细胞遗传学或细胞基因组命名系统(ISCN):一些思考。
Cytogenet Genome Res. 2021;161(5):223-224. doi: 10.1159/000516654. Epub 2021 Aug 18.
5
ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.ZMYND8 调控的 IRF8 转录轴是急性髓系白血病的一个依赖性。
Mol Cell. 2021 Sep 2;81(17):3604-3622.e10. doi: 10.1016/j.molcel.2021.07.018. Epub 2021 Aug 5.
6
A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.一种联合化学、计算和体外方法鉴定 SBL-105 为急性髓系白血病细胞中新型 DHODH 抑制剂。
Oncol Res. 2022 Jan 31;28(9):899-911. doi: 10.3727/096504021X16281573507558. Epub 2021 Aug 5.
7
Acute myeloid leukemia: 2021 update on risk-stratification and management.急性髓细胞白血病:2021 年风险分层和治疗策略更新。
Am J Hematol. 2020 Nov;95(11):1368-1398. doi: 10.1002/ajh.25975.
8
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.急性髓系白血病中实施个性化医学的遗传改变和分子靶向治疗的全面综述。
J Mol Med (Berl). 2020 Aug;98(8):1069-1091. doi: 10.1007/s00109-020-01944-5. Epub 2020 Jul 3.
9
GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells.GSK-J4通过内质网应激诱导细胞周期停滞和细胞凋亡,以及GSK-J4与地西他滨在急性髓性白血病KG-1a细胞中的协同作用。
Cancer Cell Int. 2020 Jun 3;20:209. doi: 10.1186/s12935-020-01297-6. eCollection 2020.
10
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.2017 年欧洲白血病网络定义的 NPM1/FLT3-ITD 基因型对急性髓系白血病患者的影响。
Blood. 2020 Jan 30;135(5):371-380. doi: 10.1182/blood.2019002697.